Moderna (MRNA) is a biotechnology company in the Health Care sector. Listed on the NASDAQ, Moderna is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $45.99.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $45.99 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | -9.36% |
| Risk / Std Dev (Annualized) | 66.45% |
| Sharpe Ratio (rf=4.5%) | -0.21 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Biotechnology
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of -9.36% with an annualized volatility of 66.45%. The Sharpe ratio of -0.21 (assuming 4.5% risk-free rate) indicates negative risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 18.25B |
| Enterprise Value | 14.34B |
| Forward P/E | -10.94 |
| Price to Book | 2.46 |
| Price to Sales | 8.2 |
| EV/Revenue | 6.45 |
| EV/EBITDA | -6.24 |
| Profitability | | | Profit Margin | -143.55% | | Operating Margin | -131.1% | | ROE | -36.56% | | ROA | -13.09% |
| Growth | | | Revenue Growth | 260.2% |
| Financial Health | | | Total Revenue | 2.22B | | Total Debt | 1.3B | | Total Cash | 5.21B | | Free Cash Flow | -0.02B | | Operating Cash Flow | -1.47B |
| Price & Technical | | | 52W High | $59.55$ | | 52W Low | $22.28$ | | 50-Day Avg | $49.61$ | | 200-Day Avg | $38.2$ | | Beta | 1.03 | | Shares Outstanding | 0.4B | | Float Shares | 0.37B | | Insider Holdings | 7.31% | | Institutional Holdings | 78.94% | | Short Ratio | 7.48 | | Short % of Float | 17.82% |
| Analyst Targets | | | Target High | $69.0$ | | Target Low | $21.0$ | | Target Mean | $43.3$ | | Target Median | $45.0$ | | # of Analysts | 20 | | Recommendation | hold |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.